Literature DB >> 9462167

Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease.

J A van Roon1, C M Verhoef, J L van Roy, F H Gmelig-Meyling, O Huber-Bruning, F P Lafeber, J W Bijlsma.   

Abstract

OBJECTIVES: To compare peripheral type 1 (T1) and type 2 (T2) T cell activities in rheumatoid arthritis (RA) patients with that found for osteoarthritic (OA) patients and healthy controls and to correlate peripheral T1/T2 cell activity in RA with parameters of the disease.
METHODS: Peripheral blood mononuclear cells were isolated from patients with RA (n = 66), OA (n = 19), and healthy controls (n = 15). Primary T cell activity in these mononuclear cells was enhanced by means of anti-CD3/anti-CD28, which mimicks stimulation of T cells by activation of the T cell receptor and a major co-stimulatory signal. Interferon gamma (IFN gamma) production and interleukin 4 (IL4) production in the three groups were quantified as measures of T1 and T2 cell activity, respectively, and compared. Serum tumour necrosis factor alpha (TNF alpha), erythrocyte sedimentation rate (ESR), C reactive protein (CRP), and joint destruction assessed radiographically of RA patients were determined as parameters of disease activity and correlated with T1/T2 cell activity.
RESULTS: Peripheral T cells from RA patients produced significantly less IFN gamma and more IL4 than T cells from both age and sex matched OA patients and healthy controls. Moreover, in RA patients both a decrease in IFN gamma and an increase in IL4 production correlated with an increase in serum TNF alpha, ESR, CRP, and joint destruction.
CONCLUSIONS: These results suggest a role for differential T cell activity in RA. In view of the intra-articular T1 cell predominance the results might be explained by selective T1 cell migration into the joint or peripheral suppression of T1 cell activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9462167      PMCID: PMC1752286          DOI: 10.1136/ard.56.11.656

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  31 in total

1.  Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis.

Authors:  R J Dolhain; A N van der Heiden; N T ter Haar; F C Breedveld; A M Miltenburg
Journal:  Arthritis Rheum       Date:  1996-12

2.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

3.  CD4+ T cell inducible immunoregulatory cytokine response in rheumatoid arthritis.

Authors:  N al-Janadi; A al-Dalaan; S al-Balla; S Raziuddin
Journal:  J Rheumatol       Date:  1996-05       Impact factor: 4.666

4.  Transforming growth factor-beta and cellular immune responses in synovial fluids.

Authors:  M Lotz; J Kekow; D A Carson
Journal:  J Immunol       Date:  1990-06-01       Impact factor: 5.422

5.  Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum.

Authors:  T Saxne; M A Palladino; D Heinegård; N Talal; F A Wollheim
Journal:  Arthritis Rheum       Date:  1988-08

6.  Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids.

Authors:  A M Nouri; G S Panayi; S M Goodman
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

7.  Production of tumour necrosis factor-alpha, interferon-gamma and interleukin-2 by peripheral blood mononuclear cells of subjects suffering from rheumatoid arthritis.

Authors:  P Franchimont; A Reuter; Y Vrindts-Gevaert; M Bastings; M Malaise; C Sondag; M C Frere; P Gysen
Journal:  Scand J Rheumatol       Date:  1988       Impact factor: 3.641

8.  Expression of interferon-gamma (IFN-gamma), IL-10, IL-12 and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA).

Authors:  A Bucht; P Larsson; L Weisbrot; C Thorne; P Pisa; G Smedegård; E C Keystone; A Grönberg
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

9.  Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4.

Authors:  J A van Roon; J L van Roy; F H Gmelig-Meyling; F P Lafeber; J W Bijlsma
Journal:  Arthritis Rheum       Date:  1996-05

10.  Signals involved in T cell activation. T cell proliferation induced through the synergistic action of anti-CD28 and anti-CD2 monoclonal antibodies.

Authors:  R A Van Lier; M Brouwer; L A Aarden
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

View more
  19 in total

Review 1.  Th2 mediated regulation in RA and the spondyloarthropathies.

Authors:  J A G van Roon; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

2.  Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.

Authors:  J M van Woerkom; A A Kruize; M J G Wenting-van Wijk; E Knol; I C Bihari; J W G Jacobs; J W J Bijlsma; F P J G Lafeber; J A G van Roon
Journal:  Ann Rheum Dis       Date:  2005-04-07       Impact factor: 19.103

3.  Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies.

Authors:  J D Cañete; S E Martínez; J Farrés; R Sanmartí; M Blay; A Gómez; G Salvador; J Muñoz-Gómez
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

4.  The immune suppressive effect of dexamethasone in rheumatoid arthritis is accompanied by upregulation of interleukin 10 and by differential changes in interferon gamma and interleukin 4 production.

Authors:  C M Verhoef; J A van Roon; M E Vianen; F P Lafeber; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  1999-01       Impact factor: 19.103

5.  Prevention of adjuvant arthritis by the W3/25 anti-CD4 monoclonal antibody is associated with a decrease of blood CD4(+)CD45RC(high) T cells.

Authors:  C Pelegrí; M Castell; M Serra; M Rabanal; M Rodríguez-Palmero; C Castellote; A Franch
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

6.  A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis.

Authors:  John M Davis; Keith L Knutson; Michael A Strausbauch; Cynthia S Crowson; Terry M Therneau; Peter J Wettstein; Veronique L Roger; Eric L Matteson; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2011-06

7.  Complex pattern of Th1 and Th2 activation with a preferential increase of autoreactive Th1 cells in BALB/c mice with proteoglycan (aggrecan)-induced arthritis.

Authors:  K Holló; T T Glant; M Garzó; A Finnegan; K Mikecz; E Buzás
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

8.  Increased production of a Th2 cytokine profile by activated whole blood cells from rheumatoid arthritis patients.

Authors:  A Haddad; J Bienvenu; P Miossec
Journal:  J Clin Immunol       Date:  1998-11       Impact factor: 8.317

9.  Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease.

Authors:  D Y Chen; J L Lan; F J Lin; T Y Hsieh; M C Wen
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

10.  Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis.

Authors:  J A G van Roon; K A F M Glaudemans; J W J Bijlsma; F P J G Lafeber
Journal:  Ann Rheum Dis       Date:  2003-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.